In conversation with... Nusrat Husain, Farah Lunat, and Fehmida Motala

from Listen to The Lancet · host The Lancet

ROSHNI-2 was a multicentre, randomised controlled trial that investigated the efficacy of a culturally adapted, cognitive behavioural therapy-based intervention for postnatal depression in British south Asian women. Joining us to share their expertise and perspectives are chief investigator Professor Nusrat Husain, trial manager Farah Lunat, and service user representative Fehmida Motala.

Episode metadata supplied by the publisher feed · Published Oct 31, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

In conversation with... Nusrat Husain, Farah Lunat, and Fehmida Motala

0:00 48:44

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet?

This episode is 48 minutes long.

When was this Listen to The Lancet episode published?

This episode was published on October 31, 2024.

Can I download this Listen to The Lancet episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!